Unknown

Dataset Information

Tranexamic acid alters the immunophenotype of phagocytes after lower limb surgery.


ABSTRACT:

Background

Tranexamic acid (TXA) is an antifibrinolytic agent frequently used in elective surgery to reduce blood loss. We recently found it also acts as a potent immune-modulator in patients undergoing cardiac surgery.

Methods

Patients undergoing lower limb surgery were enrolled into the "Tranexamic Acid in Lower Limb Arthroplasty" (TALLAS) pilot study. The cellular immune response was characterised longitudinally pre- and post-operatively using full blood examination (FBE) and comprehensive immune cell phenotyping by flowcytometry. Red blood cells and platelets were determined in the FBE and levels of T cell cytokines and the plasmin-antiplasmin complex determined using ELISA.

Results

TXA administration increased the proportion of circulating CD141+ conventional den

SUBMITTER: Draxler DF 

PROVIDER: S-EPMC8996554 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature